Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803021787> ?p ?o ?g. }
- W2803021787 endingPage "774.e5" @default.
- W2803021787 startingPage "761" @default.
- W2803021787 abstract "Many cancer-related proteins are controlled by composite post-translational modifications (PTMs), but prevalent strategies only target one type of modification. Here we describe a designed peptide that controls two types of modifications of the p53 tumor suppressor, based on the discovery of a protein complex that suppresses p53 (suppresome). We found that Morn3, a cancer-testis antigen, recruits different PTM enzymes, such as sirtuin deacetylase and ubiquitin ligase, to confer composite modifications on p53. The molecular functions of Morn3 were validated through in vivo assays and chemico-biological intervention. A rationally designed Morn3-targeting peptide (Morncide) successfully activated p53 and suppressed tumor growth. These findings shed light on the regulation of protein PTMs and present a strategy for targeting two modifications with one molecule." @default.
- W2803021787 created "2018-05-17" @default.
- W2803021787 creator A5003222281 @default.
- W2803021787 creator A5005496208 @default.
- W2803021787 creator A5006352176 @default.
- W2803021787 creator A5007360264 @default.
- W2803021787 creator A5014802719 @default.
- W2803021787 creator A5030801732 @default.
- W2803021787 creator A5036254947 @default.
- W2803021787 creator A5036628042 @default.
- W2803021787 creator A5038766662 @default.
- W2803021787 creator A5044677638 @default.
- W2803021787 creator A5048704005 @default.
- W2803021787 creator A5050180203 @default.
- W2803021787 creator A5051505252 @default.
- W2803021787 creator A5065503231 @default.
- W2803021787 creator A5068473447 @default.
- W2803021787 creator A5070267154 @default.
- W2803021787 creator A5075258838 @default.
- W2803021787 creator A5080577523 @default.
- W2803021787 creator A5087176865 @default.
- W2803021787 creator A5089345972 @default.
- W2803021787 creator A5090832029 @default.
- W2803021787 date "2018-06-01" @default.
- W2803021787 modified "2023-10-17" @default.
- W2803021787 title "A Designed Peptide Targets Two Types of Modifications of p53 with Anti-cancer Activity" @default.
- W2803021787 cites W1545013699 @default.
- W2803021787 cites W1863194295 @default.
- W2803021787 cites W1965581435 @default.
- W2803021787 cites W1973748124 @default.
- W2803021787 cites W1974005173 @default.
- W2803021787 cites W1981174274 @default.
- W2803021787 cites W1982474353 @default.
- W2803021787 cites W1988579714 @default.
- W2803021787 cites W1998918975 @default.
- W2803021787 cites W2010637767 @default.
- W2803021787 cites W2019418354 @default.
- W2803021787 cites W2034330475 @default.
- W2803021787 cites W2037006599 @default.
- W2803021787 cites W2040463485 @default.
- W2803021787 cites W2042994971 @default.
- W2803021787 cites W2050259175 @default.
- W2803021787 cites W2051550400 @default.
- W2803021787 cites W2061643589 @default.
- W2803021787 cites W2090053198 @default.
- W2803021787 cites W2090324071 @default.
- W2803021787 cites W2094699873 @default.
- W2803021787 cites W2095116272 @default.
- W2803021787 cites W2103428229 @default.
- W2803021787 cites W2117059796 @default.
- W2803021787 cites W2135165486 @default.
- W2803021787 cites W2137561800 @default.
- W2803021787 cites W2148031167 @default.
- W2803021787 cites W2148213068 @default.
- W2803021787 cites W2167073702 @default.
- W2803021787 cites W2171540907 @default.
- W2803021787 cites W2179994588 @default.
- W2803021787 cites W2186118124 @default.
- W2803021787 cites W2191208987 @default.
- W2803021787 cites W2200414333 @default.
- W2803021787 cites W2207474307 @default.
- W2803021787 cites W2262414037 @default.
- W2803021787 cites W2266420598 @default.
- W2803021787 cites W2287701010 @default.
- W2803021787 cites W2296315596 @default.
- W2803021787 cites W2297938062 @default.
- W2803021787 cites W2399920983 @default.
- W2803021787 cites W2400942913 @default.
- W2803021787 cites W2409136177 @default.
- W2803021787 cites W2518890317 @default.
- W2803021787 cites W2560626128 @default.
- W2803021787 cites W2592035727 @default.
- W2803021787 cites W2594451946 @default.
- W2803021787 cites W2606704799 @default.
- W2803021787 cites W2619546163 @default.
- W2803021787 cites W2730854633 @default.
- W2803021787 cites W4237099052 @default.
- W2803021787 doi "https://doi.org/10.1016/j.chembiol.2018.03.010" @default.
- W2803021787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29681526" @default.
- W2803021787 hasPublicationYear "2018" @default.
- W2803021787 type Work @default.
- W2803021787 sameAs 2803021787 @default.
- W2803021787 citedByCount "14" @default.
- W2803021787 countsByYear W28030217872018 @default.
- W2803021787 countsByYear W28030217872019 @default.
- W2803021787 countsByYear W28030217872020 @default.
- W2803021787 countsByYear W28030217872022 @default.
- W2803021787 countsByYear W28030217872023 @default.
- W2803021787 crossrefType "journal-article" @default.
- W2803021787 hasAuthorship W2803021787A5003222281 @default.
- W2803021787 hasAuthorship W2803021787A5005496208 @default.
- W2803021787 hasAuthorship W2803021787A5006352176 @default.
- W2803021787 hasAuthorship W2803021787A5007360264 @default.
- W2803021787 hasAuthorship W2803021787A5014802719 @default.
- W2803021787 hasAuthorship W2803021787A5030801732 @default.
- W2803021787 hasAuthorship W2803021787A5036254947 @default.
- W2803021787 hasAuthorship W2803021787A5036628042 @default.
- W2803021787 hasAuthorship W2803021787A5038766662 @default.